ADR data is usually collected through spontaneous reporting systems, electronic health records, and post-marketing surveillance studies. Spontaneous reporting systems, such as the FDA's MedWatch program in the United States and the Yellow Card Scheme in the United Kingdom, rely on voluntary reports from healthcare professionals and patients. These systems allow for the collection of large datasets that can be analyzed to identify patterns and trends in drug safety.
